
“I was keen to go on a clinical trial. I wanted to try new cancer treatments and hopefully help future generations.”
This trial was comparing surgery and anastrozole (Arimidex) with anastrozole alone for breast cancer. It was recruiting women over 75 years old with breast cancer that was . The trial was supported by Cancer Research UK.
Doctors usually treated older women who have ER positive breast cancer with surgery and hormone therapy or with hormone therapy alone. But there was little research in older women to show who would benefit from having surgery as well as hormone therapy. Surgery has side effects and it is important that older women don’t have operations they don’t need.
is a type of hormone therapy called an aromatase inhibitor. It is used as standard treatment for women with breast cancer who have been through the menopause.
In this trial, women had surgery and anastrozole or anastrozole alone. The aims of this study were to find out
This trial was never finished so there are no results available. The researchers were unable to recruit enough patients.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Ms L. Wyld
Mr M. Reed
AstraZeneca
Cancer Research UK
National Institute for Health Research Cancer Research Network (NCRN)
University of Leeds
University of Sheffield
This is Cancer Research UK trial number CRUK/06/010.
Freephone 0808 800 4040
“I was keen to go on a clinical trial. I wanted to try new cancer treatments and hopefully help future generations.”